Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
261
Frequently Asked Questions
What is Market Cap of Relay Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Relay Therapeutics Inc market cap is $699.99M.
What is the 52-week high for Relay Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Relay Therapeutics Inc 52 week high is $8.19 as of September 16, 2025.
What is the 52-week low for Relay Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Relay Therapeutics Inc 52 week low is $1.78 as of September 16, 2025.
What is Relay Therapeutics Inc stock price today?
Relay Therapeutics Inc stock price today is $4.21.
What was Relay Therapeutics Inc stock price yesterday?
Relay Therapeutics Inc stock price yesterday was $4.06.
What is the PE ratio of Relay Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Relay Therapeutics Inc’s P/E ratio is -2.08.
What is the Price-to-Book ratio of Relay Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Relay Therapeutics Inc P/B ratio is 1.0472.
What is the 50-day moving average of Relay Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Relay Therapeutics Inc 50-day moving average is $3.65.
How many employess does Relay Therapeutics Inc has?